A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants
Clinical trial NCT05499260 · UNKNOWN
Trial details
- NCT number
- NCT05499260
- Sponsor
- Shanghai Zhimeng Biopharma, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-02
- Primary completion
- 2023-03-02
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.